Newswire

Newswire

Immuneering Added to the Nasdaq Biotechnology Index

CAMBRIDGE, Mass., Dec. 16, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced that it will be…